Zhang, B., Chuang, G.-Y., Biju, A., Biner, D., Cheng, J., Wang, Y., Bao, S., Chao, C. W., Lei, H., Liu, T., Nazzari, A. F., Yang, Y., Zhou, T., Chen, S. J., Chen, X., Kong, W.-P., Ou, L., Parchment, D. K., Sarfo, E. K., … Kwong, P. D. (2024). Cholesterol reduction by immunization with a PCSK9 mimic. Cell Reports, 43(6), 114285. https://doi.org/10.1016/j.celrep.2024.114285

Huang, P., Ran, J., Zhu, W., Dai, W., Tang, Y., Lian, P., Huang, X., & Li, R. (2024). PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine‐induced hepatic steatosis via both receptor‐dependent and receptor‐independent pathways. The FASEB Journal, 38(4). Portico. https://doi.org/10.1096/fj.202301748r

Wang, Y., Tinsley, B., Spolitu, S., Zadroga, J. A., Agarwal, H., Sarecha, A. K., & Ozcan, L. (2024). Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9. Journal of Lipid Research, 65(3), 100515. https://doi.org/10.1016/j.jlr.2024.100515

Dron, J. S., Patel, A. P., Zhang, Y., Jurgens, S. J., Maamari, D. J., Wang, M., Boerwinkle, E., Morrison, A. C., de Vries, P. S., Fornage, M., Hou, L., Lloyd-Jones, D. M., Psaty, B. M., Tracy, R. P., Bis, J. C., Vasan, R. S., Levy, D., Heard-Costa, N., Rich, S. S., … Khera, A. V. (2023). Association of Rare Protein-Truncating DNA Variants in APOB or PCSK9 With Low-density Lipoprotein Cholesterol Level and Risk of Coronary Heart Disease. JAMA Cardiology, 8(3), 258. https://doi.org/10.1001/jamacardio.2022.5271

Steffen, B. T., Pankow, J. S., Norby, F. L., Lutsey, P. L., Demmer, R. T., Guan, W., Pankratz, N., Li, A., Liu, G., Matsushita, K., Tin, A., & Tang, W. (2023). Proteomics Analysis of Genetic Liability of Abdominal Aortic Aneurysm Identifies Plasma Neogenin and Kit Ligand: The ARIC Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(2), 367–378. https://doi.org/10.1161/atvbaha.122.317984